Inhibition of vascular endothelial growth factor with a sequence-specific hypoxia response element antagonist

Proc Natl Acad Sci U S A. 2004 Nov 30;101(48):16768-73. doi: 10.1073/pnas.0407617101. Epub 2004 Nov 19.

Abstract

Vascular endothelial growth factor (VEGF) and its receptors have been implicated as key factors in tumor angiogenesis that are up-regulated by hypoxia. We evaluated the effects of DNA-binding small molecules on hypoxia-inducible transcription of VEGF. A synthetic pyrrole-imidazole polyamide designed to bind the hypoxia response element (HRE) was found to disrupt hypoxia-inducible factor (HIF) binding to HRE. In cultured HeLa cells, this resulted in a reduction of VEGF mRNA and secreted protein levels. The observed effects were polyamide-specific and dose-dependent. Analysis of genome-wide effects of the HRE-specific polyamide revealed that a number of hypoxia-inducible genes were down-regulated. Pathway-based regulation of hypoxia-inducible gene expression with DNA-binding small molecules may represent a new approach for targeting angiogenesis.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Base Sequence
  • DNA Primers
  • Electrophoretic Mobility Shift Assay
  • HeLa Cells
  • Humans
  • Hypoxia / metabolism*
  • Microscopy, Confocal
  • Promoter Regions, Genetic
  • RNA, Messenger / genetics
  • Reverse Transcriptase Polymerase Chain Reaction
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors*
  • Vascular Endothelial Growth Factor A / genetics

Substances

  • DNA Primers
  • RNA, Messenger
  • Vascular Endothelial Growth Factor A